Across TCGA pan-cancer cohorts, MTND4LP30 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MTND4LP30’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where MTND4LP30 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MTND4LP30 is over-expressed in tumor, although a few such as KIRC and KIRP show the opposite, repressed pattern.

KICH, KIRC, and KIRP are the cancer types where MTND4LP30 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTND4LP30 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	Female	All	+1.107	<.001	4	view →
KIRC	Male	IV	−0.585	.019	3	view →
KIRP	Female	II,III,IV	−1.014	.014	2	view →
PRAD	All	All	+0.379	.008	2	view →
LIHC	All	All	−0.251	.008	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: MTND4LP30 RNA expression & survival · all MTND4LP30 data types